GeneDx Decoded published new research from Seattle Children's exploring the impact of rapid genome sequencing beyond the ICU and its potential to support earlier answers across pediatric care settings.
Public source
Publisher name
Public post
What happens when a diagnosis changes everything? The newest edition of GeneDx Decoded explores the impact of earlier genetic answers through patient stories, new resear…
Company
GeneDx
Empowering everyone to live their healthiest life through genomics
- Industry
- Biotechnology Research
- Location
- Stamford, US
- Company size
- 1,001–5,000 employees
About GeneDx
We see a world where every genetic condition is understood, and every patient receives the care they need to live their healthiest life through genomics. GeneDx combines unmatched clinical expertise, advanced technology, and the power of GeneDx Infinity™, the world’s largest rare disease genomic dataset. This unparalleled foundation powers GeneDx’s ExomeDx™ and GenomeDx™ tests – ranked #1 by expert geneticists and granted FDA Breakthrough Device Designation – enabling clinicians to deliver precise, fast, and actionable diagnoses. With over 25 years of innovation, more than 4,800 genetic diseases diagnosed, and over 1,000 scientific publications, we’re building the genomic intelligence network that’s shaping the future of precision medicine: for patients, providers, and partners alike.
See moreLatest activity
Latest activity from GeneDx
23 signals
Presence & Recognition
GeneDx launched a new educational series exploring real pediatric critical care cases where genomic answers helped guide more informed care decisions.
People
GeneDx employee Tori Al-Hark was named the August 1 Mindset Champion.
People
GeneDx employee Sarah Waltho was named the August 1 Best Pivot.
Discover more
Similar signals
Similar public activity from other companies.
Products & Services
Baylor Genetics
Baylor Genetics offers Rapid Whole Genome Sequencing (rWGS) as a first-tier test for infants and children in the NICU/PICU to accelerate diagnosis and shorten hospital stays.
Research & Knowledge
Genomics England
Genomics England published new research showing that making genomic datasets more ancestrally diverse could make rare conditions diagnoses fairer and more accurate for everyone.
Research & Knowledge
Ambry Genetics
Ambry Genetics published a research article in the Gene Scene exploring DSC2 and its association with DSC2-related arrhythmogenic right ventricular cardiomyopathy (ARVC).
Research & Knowledge
Variantyx
Variantyx published a case study involving a 14-month-old patient presenting with profound global developmental delay and multiple congenital anomalies, including complex craniofacial features, cardiac defects, and skeletal abnormalities, who was tested with Variantyx Genomic Unity® and had negative results after a year of rapid whole genome trio testing in the NICU.
Research & Knowledge
CENTOGENE